The long-awaited revised USP <797> guidelines will become official on November 1, 2023.
Evidence of the relationship between probiotics and antibiotics is lacking.
The COVID-19 pandemic and social media have resulted in extreme levels of misinformation.
Relyvrio is intended to slow the disease progression of amyotrophic lateral sclerosis.
There may not be a diagnosis for ‘New Year Depression,’ but about 10% to 20% of individuals in the US may get a milder form of these winter blues.
Stimulant medications are the first-line pharmacologic therapy for ADHD, but many of these medications are currently in short supply.
Does anxiety justify an exemption from vaccine mandates among health care workers?
Evidence suggests some pharmaceutical excipients in medications may have adverse effects on pediatric patients. Here’s what you should know.
Efforts to improve education on biosimilars are a start, but payer policies must catch up to ensure real change.
On June 25, 2020, fenfluramine (Fintepla) was approved for the treatment of seizures associated with Dravet syndrome in patients 2 years and older.
During COVID-19, pharmacy technicians helped keep immunization programs running.
Developing innovative solutions for women with depression, accounting for differences in gender and sex, are critically important
From compounding to cleaning, oncology pharmacy technicians take on key responsibilities in infusion centers.
The existing approach to disease management may be ill-suited to address the dynamic and diverse factors at play when it comes to chronic illness.
GLP-1 receptor agonists, used to manage diabetes, are now being used for obesity in children and adolescents.
A deep dive for pharmacists into this frequently debilitating disorder
Matthew Zirwas, MD, shares his step-by-step pearls for quelling the pruritic skin condition.
The drug’s approval was based on the results of 3 clinical trials.
Stimulant medications are the first-line pharmacologic therapy for ADHD, but many of these medications are currently in short supply.
Developing innovative solutions for women with depression, accounting for differences in gender and sex, are critically important
Researchers used an online English-language survey questionnaire to collect data on pharmacists from Germany and Switzerland about how their knowledge and dispensing frequency of biologics and biosimilars changed from before and after the pandemic.
Often referred to as “long COVID” patients or “long-haulers,” these patients continue to experience symptoms of illness far past the acute phase of this viral disease.
A perspective on the CMS Innovation Center roundtable on health equity.
As respiratory viruses and COVID-19 variants lurk seemingly everywhere, here’s how best to detect and differentiate.
Protection from the harsh rays of the sun is crucial for everyone—including children. Now that summer has arrived, a refresher course can go a long way in preventing skin damage and disorders due to the sun.
Zavegepant joins other CGRP antagonists as an option for individuals experiencing migraine.
An expert panel discusses where bempedoic acid currently fits into the treatment of hypercholesterolemia.
Todd Mizeski, Esq, a Partner in Frier Levitt’s Life Sciences, Litigation Department, discusses the case of Rutledge v. Pharmaceutical Care Management Association.